-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Financial App News, Shijiyao Group (02005.HK) issued an announcement. The Group has obtained registration approvals from the China National Drug Administration (CFDA) for the production of low-calcium peritoneal dialysis solution (bicarbonate G 1.5%), peritoneal dialysis solution (bicarbonate-G 2.5%), peritoneal dialysis solution (bicarbonate-G 4.25%), and low-calcium peritoneal dialysis solution (bicarbonate-G 4.25%) (such products), all of which are 2000ml chemicals and belong to Class 3 It is considered to have passed the consistency evaluation, including low-calcium peritoneal dialysis solution (carbonic acid Hydrogen salt-G 4.25%) is the third domestic company to be approved. These products are mainly used for peritoneal dialysis in patients with chronic renal failure, and are used when hypermagnesemia has not been sufficiently improved.
Share
Listen to the news
Zhitong Financial App News, Shijiyao Group (02005.HK) issued an announcement. The Group has obtained registration approvals from the China National Drug Administration (CFDA) for the production of low-calcium peritoneal dialysis solution (bicarbonate G 1.5%), peritoneal dialysis solution (bicarbonate-G 2.5%), peritoneal dialysis solution (bicarbonate-G 4.25%), and low-calcium peritoneal dialysis solution (bicarbonate-G 4.25%) (such products), all of which are 2000ml chemicals and belong to Class 3 It is considered to have passed the consistency evaluation, including low-calcium peritoneal dialysis solution (carbonic acid Hydrogen salt-G 4.25%) is the third domestic company to be approved. These products are mainly used for peritoneal dialysis in patients with chronic renal failure, and are used when hypermagnesemia has not been sufficiently improved.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending